This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffin, R.
Right arrow Articles by Hood, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffin, R.
Right arrow Articles by Hood, D. W.

 Previous Article  |  Next Article 

Infection and Immunity, April 2005, p. 2213-2221, Vol. 73, No. 4
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.4.2213-2221.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Elucidation of the Monoclonal Antibody 5G8-Reactive, Virulence-Associated Lipopolysaccharide Epitope of Haemophilus influenzae and Its Role in Bacterial Resistance to Complement-Mediated Killing

Ruth Griffin,1* Andrew D. Cox,2 Katherine Makepeace,1 James C. Richards,2 E. Richard Moxon,1 and Derek W. Hood1

Molecular Infectious Diseases Group, University of Oxford Department of Paediatrics, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom,1 Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada2

Received 11 August 2004/ Returned for modification 7 October 2004/ Accepted 18 November 2004

The phase-variable locus lex2 is required for expression of a Haemophilus influenzae lipopolysaccharide (LPS) epitope of previously unknown structure. This epitope, which is reactive with monoclonal antibody (MAb) 5G8, has been associated with virulence of type b strains. When strain RM118 (from the same source as strain Rd), in which the lex2 locus and MAb 5G8 reactivity are absent, was transformed with lex2 DNA, transformants that were reactive with MAb 5G8 were obtained. Surprisingly, the 5G8 reactivity of these transformants was phase variable, although the lex2 locus lacked tetrameric repeats and was constitutively expressed. This phase variation was shown to be the result of phase-variable expression of phosphorylcholine (PCho) such that MAb 5G8 reacted only in the absence of PCho. Structural analysis showed that, compared to RM118, the lex2 transformant had acquired a tetrasaccharide, Gal-{alpha}1,4-Gal-ß1,4-Glc-ß1,4-Glc-ß1,4, linked to the proximal heptose (HepI). A terminal GalNAc was detected in a minority of glycoforms. LPS derived from a mutant of RM7004, a virulent type b strain which naturally expresses lex2 and has LPS containing the same tetrasaccharide linked to HepI as the sole oligosaccharide extension from the inner core, confirmed that GalNAc is not a part of the MAb 5G8-reactive epitope. Thus, MAb 5G8 specifically binds to the structure Gal-{alpha}1,4-Gal-ß1,4-Glc-ß1,4-Glc-ß attached via a 1,4 linkage to HepI of H. influenzae LPS, and we show that the ability to synthesize this novel tetrasaccharide was associated with enhanced bacterial resistance to complement-mediated killing.


* Corresponding author. Present address: Centre for Molecular Microbiology and Infection, Level 3, Flowers Building, Imperial College, London SW7 2AZ, United Kingdom. Phone: 020 7594 3094. Fax: 020 7594 3095. E-mail: r.griffin{at}imperial.ac.uk.

Editor: J. N. Weiser


Infection and Immunity, April 2005, p. 2213-2221, Vol. 73, No. 4
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.4.2213-2221.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Deadman, M. E., Hermant, P., Engskog, M., Makepeace, K., Moxon, E. R., Schweda, E. K. H., Hood, D. W. (2009). Lex2B, a Phase-Variable Glycosyltransferase, Adds either a Glucose or a Galactose to Haemophilus influenzae Lipopolysaccharide. Infect. Immun. 77: 2376-2384 [Abstract] [Full Text]  
  • Ho, D. K., Ram, S., Nelson, K. L., Bonthuis, P. J., Smith, A. L. (2007). lgtC Expression Modulates Resistance to C4b Deposition on an Invasive Nontypeable Haemophilus influenzae. J. Immunol. 178: 1002-1012 [Abstract] [Full Text]  
  • Erwin, A. L., Allen, S., Ho, D. K., Bonthius, P. J., Jarisch, J., Nelson, K. L., Tsao, D. L., Unrath, W. C. T., Watson, M. E. Jr., Gibson, B. W., Apicella, M. A., Smith, A. L. (2006). Role of lgtC in Resistance of Nontypeable Haemophilus influenzae Strain R2866 to Human Serum. Infect. Immun. 74: 6226-6235 [Abstract] [Full Text]  
  • Erwin, A. L., Bonthuis, P. J., Geelhood, J. L., Nelson, K. L., McCrea, K. W., Gilsdorf, J. R., Smith, A. L. (2006). Heterogeneity in Tandem Octanucleotides within Haemophilus influenzae Lipopolysaccharide Biosynthetic Gene losA Affects Serum Resistance.. Infect. Immun. 74: 3408-3414 [Abstract] [Full Text]  
  • Griffin, R., Bayliss, C. D., Herbert, M. A., Cox, A. D., Makepeace, K., Richards, J. C., Hood, D. W., Moxon, E. R. (2005). Digalactoside Expression in the Lipopolysaccharide of Haemophilus influenzae and Its Role in Intravascular Survival. Infect. Immun. 73: 7022-7026 [Abstract] [Full Text]